Previous research demonstrated the inhalation teratogenicity of the solvent 2-ethoxyethanol in rats and rabbits. As this is one of a class of widely used industrial solvents, we investigated the teratogenicity of five structurally related compounds. Each chemical was vaporized and administered to approximately 15 pregnant rats in one to three concentrations for 7 hr/day on gestation days 7 to 15, and dams were sacrificed on day 20. Fetuses were individually weighed, and two-thirds of them were fixed in Bouin's solution and examined for soft-tissue anomalies. The other one-third were fixed in alcohol, stained with Alizarin Red and examined for skeletal defects. Data were analyzed on a litter basis; three solvents were compared with a pooled group (N = 34) of sham-exposed controls, and the remaining two were compared with a group of 15 controls. At concentrations which were apparently not maternally toxic, 2-methoxyethanol was highly embryotoxic, producing complete resorptions at 200 ppm; increased resorptions, reduced fetal weights and skeletal and cardiovascular defects occurred at both 100 and 50 ppm. 2-ethoxyethyl acetate at 600 ppm induced complete resorption of litters; 390 ppm reduced fetal weights and induced skeletal and cardiovascular defects, but only a single defect was observed at 130 ppm. 2-Butoxyethanol evidenced slight maternal toxicity at 200 ppm but produced no increase in congenital defects at that concentration. Neither 2-(2-ethoxyethoxy)ethanol (100 ppm) nor 2-methylaminoethanol (150 ppm) was maternally toxic or embryotoxic. In summary, shorter alkyl chained glycol ethers produced greater embryotoxicity than those having longer chains, and the ester produced effects equivalent to the ether, both patterns predictable from the biochemical literature.
Of the thousands of chemicals to which workers are exposed, only a few have even minimal experimental animal data from which to evaluate or predict reproductive toxicity. One class of chemicals that has demonstrated reproductive toxicity is a class of monoand dialkyl ethers of ethylene glycol and their derivatives, collectively referred to as cellosolves or glycol ethers. Approximately 700 million pounds (318 thousand metric tons) of glycol ethers were produced in 1977, with the ethylene glycol monoethers representing about 78% of the total production (1) . Ethoxyethanol, the prototype of this class, has the largest production volume, followed by butoxyethanol and methoxyethanol (1) ,ug/kg/day IP injections of ethoxyethanol throughout gestation, although no defects were noted in mice or rabbits (2) . The same investigators administered ethoxyethanol at 400 ,uL/kg/day for 4 weeks or 200 ,uL/kg/day for 13 weeks to male rats and observed testicular damage after both exposure regimens. Recently increased skeletal variations were observed following intubation of doses as low as 31.25 mg/kg/day methoxyethanol on gestation days 7 to 14 in mice (3) .
Only recently, however, have there been reports of teratogenic effects produced by the glycol ethers after administration using the common routes of occupational exposure, inhalation and cutaneous absorption. Skeletal and cardiovascular defects were observed in rats after dermal exposure to 1.0 mL (0.25 mL, four times/day) ethoxyethanol on gestation days 7 to 16 , with nearly half of the litters entirely resorbed at that level, and all litters completely resorbed at twice that level (4) . Gestational exposure via inhalation to 600 to 750 ppm ethoxyethanol produced complete embryomortality in rats and rabbits, whereas 200 or 160 ppm ethoxyethanol induced skeletal and cardiovascular defects in rats and rabbits, respectively (5) . Increased neonatal mortality following inhalation exposure of pregnant rats to ethoxyethanol at the current Federal occupational standard (200 ppm) and behavioral and neurochemical alterations in the offspring of pregnant rats exposed to one-half that concentration (viz. 100 ppm) have been reported (6) .
Dose-dependent increases in testicular atrophy have been reported in mice following oral administration of various glycol ethers at 250 to 4000 mg/kg/day, 5 days/week for 5 weeks (7). The lowest levels causing significant deviations from controls were as follows: methoxyethanol 250 mg/kg, methoxyethyl acetate 500 mg/kg; ethoxyethanol 1000 mg/kg, ethoxyethyl acetate 1000 mg/kg; butoxyethanol and phenoxyethanol produced mortality in all rats at 2000 mg/kg but had no effect on testicular weight at 1000 mg/kg. The most important implication of these results is the indication that the chemicals having shorter attached alkyl groups produced the most damage and that reproductive toxicity decreases with increasing chain length. Esterification of the compounds (i.e, the acetate forms) resulted in less testicular atrophy when the dose was calculated on a weight per body weight (mg/kg) basis (at least with methoxyethanol), but produced effects equivalent to those of the alcohol form when calculated on a molar basis (thus implying that the acetate was removed prior to the toxic action).
The present research evaluated the teratogenic effects of structurally related glycol ethers in an attempt to determine the structure activity relationships for teratogenicity. 
Apparatus and Procedures
Males weighing over 300 g were placed individually into a cage with three females weighing 200 to 300 g. 
Statistical Analysis
Numbers of implants and proportions of resorptions were independently analyzed by using a Kruskal-Wallis aDue to equipment problems, suitable data for concentrations from the infrared analyzer were not available for these chemicals. bGas chromatograph samples were not taken in these exposures. cThis charcoal tube result is approximately 15% higher than that from the infrared analyzer (IR); since the IR provided an essentially continuous daily record of exposures, we have used the figures (usually rounded to the nearer 10 ppm) from the IR throughout the text for all chemicals where suitable data from the IR were available. Where IR data were not available, the charcoal tube results were used within the text. test corrected for ties, with subsequent multiple comparisons to determine where the differences occurred (12) . Analysis of pup weights involved a mixed model analysis of covariance (with the number of live pups in the litter as the covariate) using maximum likelihood estimation (13, 14) . The model was mixed, since there was both within-litter and between-litter variation. Subsequently, pairwise comparisons between the pooled control group and each treatment group were performed. Incidence of total defects and of total variants were compared using a Kruskal-Wallis test with multiple comparisons (12) with the litter as the experimental unit and the level of significance at p< 0.05.
Results
The concentrations within the exposure chambers as measured by the infrared analyzer were relatively close to those obtained from gas chromatography (Table 2 ).
Control
No visceral or skeletal malformations were observed in fetuses from control dams. The types of visceral and skeletal variants observed in fetuses from the control treated dams were similar to those variants observed in chemically exposed groups.
Methoxyethanol (ME)
Concentrations of ME (Table 2) were easily generated and were rapidly cleared from the exposure chambers. There were no overt signs of toxicity in the pregnant rats in any of the groups. The Visceral malformations (Table 4) were found in fetuses from both the 50 ppm and 100 ppm ME-treated dams, but only the incidence of those from the 100 ppm group was significantly different from the controls (p S 0.025). Heart abnormalities were the predominant malformations observed in both the 100 ppm and 50 ppm ME groups. Malformations of the retina, eye, umbilicus and lungs of ME-exposed fetuses were also observed but at a frequency lower than the aforementioned.
Wavy, fused, and absent ribs, plus extra vertebrae were observed in the 100 and 50 ppm ME treatment groups (Table 5) . Additionally, tail malformations were observed in the 100 ppm group. Statistical analyses of these pooled data indicate significant differences from controls for both the 50 ppm (p < 0.025) and 100 ppm (p < 0.05) treatment groups. Fetuses in the 50 ppm group demonstrated more rib malformations than fetuses in the 100 ppm group. The failure of the incidence of malformations to increase with dose may be the result of increased embryo lethality observed in the high dose group. These data indicate that inhalation of 50 or 100 ppm ME is teratogenic in the rat. (8) 3 (5) 17 (13) 12 (9) Visceral variants observed in fetuses from both ME-treated groups were similar to those variants observed in control fetuses (Thble 6); however, their frequency in exposed groups was significantly increased above that for the control group (p < 0.01). Skeletal variants were significantly more numerous in fetuses from both the 50 (p < 0.01) and 100 ppm (p < 0.025) ME-exposed dams than were variants in fetuses from control dams (Table 7 ). These data indicate that inhalation of ME did cause growth retardation in the rat.
Butoxyethanol (BU)
Concentrations of BU were more difficult to generate in that the solvent required heat to generate even the low concentrations. Clearance time from the chambers was also longer than for ME. This was the only one of the chemicals which produced apparent maternal toxicity [ranging from hematuria, as has been reported in the literature (15) , to death at concentrations from 250 to 500 ppm. Based on the maternal toxicity, In a dose finding study conducted at the outset of the project, nonpregnant rats (250-300 g) were exposed to 250, 350 or 450 to 500 ppm BU (no charcoal tube verification). Three of four rats exposed to 450 to 500 ppm of BU for 6.5 hr died within 36 hr after termination of exposure levels of 150 and 200 ppm were chosen for the teratology study.
Pregnant rats exposed to 200 ppm BU showed some hematuria, but only on the first day of exposure. With that exception, the dams showed no adverse effects. There was a significant increase in the mean number of implants in the 200 ppm BU group, but since no treatment began until day 7, this increase was not treatment-related. There was also no apparent adverse effect upon the pups, as the number of resorptions, fetal weights, and incidence of malformations did not differ from controls (Tables 3-7) . (There was a statistically significant decrease in fetal weights in the 150 ppm BU groups, but since the differences were slight and there were no effects at the higher level, these differences exposure, and two of three nonpregnant rats died within 18 hr after exposure to approximately 350 ppm BU for 7 hr. Of three nonpregnant rats exposed for 7 hr to 250 ppm BU, one died within 18 hr after exposure, and a second died after day 2 of exposure. With each of these concentrations, the exposed rats began showing various (legrees of hematuria 4 to 6 hr after onset of exposure, as has been reported elsewhere (15) . From each of these concentrations, one rat survived, and these three animals were placed together in a 41 x 32 x 18-cm steel cage. Approximately 1 week after exposure, the distal portion of the tail (about one-half the tail length) became necrotic and fell off or was chewed off. Observations of a small number of singly housed rats exposed cutaneously to butoxyethanol woul(d suggest that each rat chewed its own tail off. (2) 16 (30) 3(2) 15 (28) 2(2) 17 (32) 3 (6) 3 (10) 4 (6) 0 0 0 0 12 (39) 9 (13) 16 (52) 
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2-Ethoxyethyl Acetate (EEAC)
Concentrations of EEAC were relatively easy to generate and cleared rapidly from the chamber. Maternal animals showed no overt toxicity; a weight reduction was observed at higher concentrations, but this was likely due to increased resorptions. As shown in Table  3 , all offspring from dams exposed to 600 ppm EEAC were resorbed. At 390 ppm there was a significant increase in resorptions and fetal weights were reduced by 21%, and at 130 ppm there were slight but significant decreases in fetal weights.
Visceral malformations of the heart and umbilicus were observed in fetuses from the 390 ppm EEACtreated dams (Table 4) . Only one fetus from the 130 ppm group had a heart defect. Statistical analysis of the data indicated significant differences between EEAC treated and control groups (p < 0.01); furthermore, since heart defects rarely occur spontaneously, and none were observed in control fetuses, these data indicate that inhalation of either 130 ppm of 390 ppm EEAC is teratogenic in the rat. Malformations of the ribs were observed in three fetuses from 390 ppm EEAC-exposed dams (Table 5) ; no skeletal malformations were observed in fetuses from the 130 ppm EEAC group. Statistical analysis of these data indicated significant differences from the controls (p < 0.01); however, due to the low frequency of occurrence of these malformations, treatment-induced cause cannot be positively concluded.
Visceral variants observed in fetuses from EEACtreated dams were similar to those variants observed in control fetuses (Table 6) ; however, the frequency of variants in the exposed groups was significantly different from the control-treated group Significant statistical differences in skeleltal variants (Table 7) were observed between control and 130 ppm (p < 0.05) and 390 ppm (p < 0.01) and also between 130 ppm and 390 ppm treatment groups (p < 0.01). (p < 0.05). These data indicate that inhalation of EEAC at either dose level during the period of organogenesis can cause growth retardation in the rat.
2-(2-Ethoxyethoxy)ethanol (Carbitol, 2-EEE)
Due to the low vapor pressure of 2-EEE, higher concentrations could not be tested due to probable formation of an aerosol (this was observed during chamber calibration). No toxicity was observed in maternal animals or in the offspring (Tables 8-10 ) after exposure to 100 ppm 2-EEE (mean concentration from 65 charcoal tubes or 2 to 3 per day = 102 ppm).
Consequently, 2-EEE is likely not a teratogenic hazard after inhalation exposure. Nor is it of teratogenic risk when given in comparable molar equivalents to a cutaneously teratogenic (4) level of ethoxyethanol (Nelson, unpublished observations).
2-Methylaminoethanol (2-MAE)
Low vapor pressure also prevented our generating high concentrations of 2-MAE. At 150 ppm 2-MAE (mean concentration from 28 silica gel tubes, one per day, analyzed in duplicate = 150.0 ppm), no maternal or fetal toxicity was observed (Tables 8-10 ).
Discussion
In this study of the inhalation teratogenic effects of four glycol ethers and an amino derivative, methoxyethanol was the most embryotoxic; ethoxyethyl acetate was less potent; but butoxyethanol, 2-(2-ethoxyethoxy)-ethanol, and 2-methylaminoethanol were not embryotoxic at the concentrations tested. Congenital malformations in mice have been reported after the mice were intubated with various levels of ME on gestation days 7-14 (3) . Comparing the frequency of resorptions in that study with the frequency of resorptions we observed, it appears that our level of 100 ppm ME would roughly correspond to their dose of 250 mg/kg. At one half that level (50 ppm and 125 mg/kg) in both studies, there was little increase in resorptions, but malformations were observed. Since the study in mice (3) found malformations at levels lower than this (even at their lowest dose of 31.25 mg/kg), it is possible that malformations could be induced by concentrations lower than our low level of 50 ppm.
The results from ethoxyethyl acetate were as expected. Based upon the ubiquitous nature of the esterases within the body, and upon work with testicular atrophy (7), we had predicted at the outset of the study that, calculated on a molar basis, EEAC would have precisely the same effects as ethoxyethanol (EE). Consequently, 600 ppm EEAC was expected to, and did, induce complete embryomortality as 600 ppm EE had done (5, 16) . At 390 ppm EEAC, resorptions were only slightly increased, though fetal weights were depressed and malformations were observed. At 130 ppm EEAC, fetal weights were still depressed and there was one defective fetus, indicating that this level is near the teratogenic threshold but should still be considered teratogenic in the rat. Thus, there is a relatively steep dose-effect curve with EEAC, and the same can be said of 2-ethoxyethanol and ME.
Butoxyethanol appears to be rather unique in this series, in that it produces maternal toxicity at levels below those which produce embryotoxicity. Its toxicity and hemolytic effects have been described (15) , with a recent study verifying and extending the previous report (17) . The same investigators also indicated (15) that the likely metabolic product is butoxyacetic acid, and that the majority of the metabolite is excreted within 24 hr. That the excretion is fairly rapid is also suggested from our results in that the hematuria was observed only on the first day of exposure. As is apparently true with most of the glycol ethers, BU is readily absorbed through the skin (18) . Our incidental observation of necrosis in the tails of rats exposed to BU was not noted in the literature. Whether the necrosis was due to damage in the extremity of the peripheral nervous system (in the tail) or to the lack of oxygen and nutrients provided by the blood of the region is unknown, though the known effects of BU on the blood suggest the latter as a strong possibility.
Theoretically, one of the biotransformation products of 2-EEE would be 2-ethoxyethanol (or its biotransformation products). Thus it may be that high levels of 2-EEE would be teratogenic, though this remains as only speculation since we could not generate higher levels of 2-EEE as a vapor. Considering all of these results in conjunction with the previously reported teratogenic effects of 2-ethoxyethanol, it appears that longer chain glycol ethers are less embryotoxic than the short-chain glycol ethers; this would be expected due to the relatively lower lipid solubilities of the longer chain compounds (19) . Further, based on our results with 2-ethoxyethyl acetate, it is likely that the acetates of other glycol ethers would have similar reproductive toxicity to their corresponding ethers.
Finally, the lack of teratogenic response of 2-methylaminoethanol was interesting and from a mechanistic or theoretical point of view, would merit follow up using a different route of exposure. At first glance, one might expect that its biotransformation would be similar to that of 2-ME. However, our results of no maternal or fetal toxicity at 150 ppm 2-MAE suggest that this may not be the case; since the amine is likely more lipidsoluble and less water-soluble than the methoxy portion, the absorption and excretion of the 2-MAE is likely quite different from that of 2-ME. Thus it would be of interest to see if a higher dose of 2-MAE would be teratogenic, though a route other than inhalation would be required, since the vapor concentration we used was near the saturation point.' This lack of teratogenicity at three times the concentration of a teratogenic level of its structurally similar glycol ether, points to a relatively strict structural requirement to produce teratogenic effects.
The present study does not elucidate the mechanism of action by which the solvents induce embryotoxicity. Nor did we determine biotransformation pathways, though it is likely that each glycol ether undergoes * One purpose of this study was to select another glycol ether for inclusion in a behavioral teratology study. As exposure to 200 ppm 2-ethoxyethanol on gestation days 14-20 was previously reported to cause neonatal deaths (6) , small groups of animals were also exposed to the chemicals in the present study on gestation days 14-20. Maternal animals reared their young (litters culled to four female and four male pups on the day of birth) to weaning, and the offspring were weighed weekly for 5 weeks. The results indicated that 100 ppm 2-ME (N = 6) delayed parturition by approximately 36 hr and no pups survived for 1 week; 50 ppm 2-HE (N = 5) produced little, if any, delay in parturition, and all pups survived. Exposure to 600 ppm EEAC (N = 3) delaved parturition by around 24 hr and produced 75% mortality in the offspring; 390 ppm (N = 3) delayed parturition by about 12 hr, but all offspring survived; neither 130 ppm EEAC (N = 4) nor 150 ppm BU (N = 4) produced any adverse effects in the offspring. biotransformation via alcohol and aldehyde dehydrogenase, yielding its corresponding acetaldehyde and subsequently excreted primarily as the acetic acid derivative. We observed that embryotoxicity decreases as alkyl chain length increases, similar to observations with testicular atrophy (7). We found that short-chain glycol ethers and their corresponding esters are embryotoxic and teratogenic in rats. Since previous research found similar effects induced by methoxyethanol in mice via intubation (3) and ethoxyethanol in rabbits (5) via inhalation, and in rats via cutaneous exposure (4), teratogenic effects have been induced in three lower species of animals by common routes of human exposure. Such effects call for careful examination of human populations exposed to this class of solvents, particularly since these effects in animals were observed at concentrations which are at or below current permissible exposure limits.
NOTE: Since the time this paper was prepared, there has been a proliferation of research on the glycol ethers; we refer readers to the other paper in this issue for more recent research.
